Actively Recruiting
The Links Between Executive and Linguistic Processes and Their Lesional Determinants From a Verbal Fluency Task
Led by Centre Hospitalier Universitaire, Amiens · Updated on 2025-05-25
302
Participants Needed
1
Research Sites
337 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Verbal fluency test require to produce as much words as possible in one or two minutes. This test is highly sensitive to main brain diseases and are therefore widely used in clinical routine for diagnostic purpose. The verbal fluency task requires several cognitive processes including executive and linguistic processes for which it is difficult to extract the origin of the deficit. For this reason, fluency tests are variably interpreted in terms of executive or language. The implementation of an experimental protocol exploring each of these processes separately and studying the links between the verbal fluency task and each of these processes should allow a better understanding of the origin of the verbal fluency deficit after brain injury and improve the identification of key brain structures. Indeed, the lesion determinants of this task remain to be clarified despite remarkable advances due to the evolution of imaging techniques (voxel-based lesion-symptom mapping (VLSM); voxel-based morphometry (VBM)). Furthermore, while the direct assessment of linguistic process, semantic memory, and processing speed is well defined, the examination of the executive component (i.e., strategic search process) remains unsettled and will be undertaken in this study. This work will take advantage of data from previous multicenter work, validated methodologies for both analysis and interpretation of cognitive performance as well as anatomic-clinical correlations at the voxel level and will be performed in cognitive neurodegenerative and cerebrovascular disease.
CONDITIONS
Official Title
The Links Between Executive and Linguistic Processes and Their Lesional Determinants From a Verbal Fluency Task
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients with cognitive cortical neurodegenerative diseases
- Patients between 40 and 85 years old
- French native speakers
- Affiliated to Social Security
- Able to read, write, count up to 36, and know the alphabet
- Assessed at Amiens University Memory Clinic for mild or major cognitive impairment related to AD, DCL, FTLD, CBD, or PSP
- Stroke patients with informed consent, between 40 and 85 years old
- Stroke patients with French native language and Social Security affiliation
- Stroke patients able to read, write, count up to 36, and know the alphabet
- Stroke patients hospitalized in neurology with stroke confirmed by imaging
You will not qualify if you...
- Mental retardation or under guardianship
- Other brain conditions affecting cognition such as severe head trauma, epilepsy prior to stroke requiring treatment, Parkinson disease, multiple sclerosis, brain tumor, or brain radiation therapy
- Current or past schizophrenia or psychosis
- Psychiatric impairments requiring hospitalization longer than 2 days
- Contraindication to MRI
- Life expectancy less than 1 year due to comorbidities
- Comorbidities affecting cognition including alcohol abuse, opiate or cocaine addiction, renal failure, hepatic failure, respiratory failure, heart failure, and persistent vigilance disorder
- Cancer with paraneoplastic syndrome
- Treatment with gold salts, D Penicillamine, or other drugs affecting cognition
- Patients under guardianship or curators
- Pregnant or breastfeeding women
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
CHU Amiens
Amiens, France, 80054
Actively Recruiting
Research Team
M
Martine ROUSSEL, PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
DIAGNOSTIC
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here